As Courts Punt CBD Class Actions, Attys Wait For FDA To Act
A string of federal courts have paused consumer class actions against CBD companies until the U.S. Food and Drug Administration issues long-anticipated rules governing the products, but litigants say the regulations,...To view the full article, register now.
Already a subscriber? Click here to view full article